Kocak Ron 4
4 · RenovoRx, Inc. · Filed Feb 12, 2024
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Kocak Ron
VP, Controller and PAO
Transactions
- Award
Options
2024-02-09+15,000→ 15,000 totalExercise: $1.59→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Represents 10-year incentive stock options to purchase 15,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning vesting on the date.